Therefore, the predictive power of these three prognostic lncRNAs (MME-AS1, CSMD2-AS1 and CTC-467M3.1) was analyzed using the completely independent Hummel dataset of 159 DLBCL patients. This evidence concerns the gene CSMD2 and diffuse large B-cell lymphoma.